ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,580,000 | -13.2% | 230,417 | -16.4% | 0.04% | -7.3% |
| Q4 2021 | $6,432,000 | +40.5% | 275,560 | 0.0% | 0.04% | +32.3% |
| Q3 2021 | $4,577,000 | -31.9% | 275,560 | 0.0% | 0.03% | -32.6% |
| Q2 2021 | $6,721,000 | -56.2% | 275,560 | -7.8% | 0.05% | -64.1% |
| Q1 2021 | $15,348,000 | -3.9% | 298,888 | 0.0% | 0.13% | +1.6% |
| Q4 2020 | $15,979,000 | +25.4% | 298,888 | -3.3% | 0.13% | +5.0% |
| Q3 2020 | $12,746,000 | +10.0% | 309,000 | +29.3% | 0.12% | -1.6% |
| Q2 2020 | $11,585,000 | +246.2% | 239,000 | +198.8% | 0.12% | +229.7% |
| Q1 2020 | $3,346,000 | -2.2% | 80,000 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $3,422,000 | +21.8% | 80,000 | -53.9% | 0.04% | -14.0% |
| Q4 2018 | $2,809,000 | -0.3% | 173,700 | +28.0% | 0.04% | +16.2% |
| Q3 2018 | $2,817,000 | +39.7% | 135,700 | +2.8% | 0.04% | +15.6% |
| Q2 2018 | $2,016,000 | +16.5% | 132,000 | +71.4% | 0.03% | +6.7% |
| Q1 2018 | $1,730,000 | -25.4% | 77,000 | 0.0% | 0.03% | -25.0% |
| Q4 2017 | $2,318,000 | -20.1% | 77,000 | 0.0% | 0.04% | -21.6% |
| Q3 2017 | $2,901,000 | -18.1% | 77,000 | -39.4% | 0.05% | -23.9% |
| Q2 2017 | $3,542,000 | +68.9% | 127,000 | +108.2% | 0.07% | +63.4% |
| Q1 2017 | $2,097,000 | -32.0% | 61,000 | -34.5% | 0.04% | -46.1% |
| Q3 2015 | $3,082,000 | -48.2% | 93,200 | -34.4% | 0.08% | -38.7% |
| Q2 2015 | $5,947,000 | +19.3% | 142,000 | -7.2% | 0.12% | +24.0% |
| Q1 2015 | $4,987,000 | -4.8% | 153,000 | -7.3% | 0.10% | -9.1% |
| Q4 2014 | $5,239,000 | – | 165,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |